JPRN-UMIN000005667招募中未知
Phase I/II study of adjuvant therapy after liver transplantation in the recipients with advanced hepoatocellular carcinoma - Phase I/II study of adjuvant therapy after LTx in the recipients with advanced HCC
Osaka University Graduate School of Medicine, Department of Surgery0 个研究点目标入组 30 人开始时间: 2011年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •renal dysfunction, ABO incompatible transplant, HIV positive, and others
研究者
相似试验
已完成
1 期
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.Pancreatic cancerJPRN-UMIN000004332Tokyo Women's Medical University20
已完成
不适用
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
招募中
不适用
A Phase I/II Trial of combined adjuvant therapy with gemcitabine and cisplatin for resected biliary tract cancerResected biliary tract cancerJPRN-UMIN000004359Shinshu University School of Medicine, Surgery33
已完成
不适用
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed dendritic cells for patients with advanced high-grade salivary gland tumor followed by standard therpies.Salivary gland tumorJPRN-UMIN000024669Chiba University Hospital6
已完成
1 期
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with high-grade salivary grand tumor followed by standard therpies.High-grade salivary grand tumorJPRN-UMIN000011509Department of Otorynolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University9